94 related articles for article (PubMed ID: 21574905)
21. Opioid use for chronic low back pain: A prospective, population-based study among injured workers in Washington state, 2002-2005.
Franklin GM; Rahman EA; Turner JA; Daniell WE; Fulton-Kehoe D
Clin J Pain; 2009; 25(9):743-51. PubMed ID: 19851153
[TBL] [Abstract][Full Text] [Related]
22. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
Simpson DM; Messina J; Xie F; Hale M
Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282
[TBL] [Abstract][Full Text] [Related]
23. Buprenorphine transdermal delivery system in adults with persistent noncancer-related pain syndromes who require opioid therapy: a multicenter, 5-week run-in and randomized, double-blind maintenance-of-analgesia study.
Landau CJ; Carr WD; Razzetti AJ; Sessler NE; Munera C; Ripa SR
Clin Ther; 2007 Oct; 29(10):2179-93. PubMed ID: 18042474
[TBL] [Abstract][Full Text] [Related]
24. Impact of noncompliance with urate-lowering drug on serum urate and gout-related healthcare costs: administrative claims analysis.
Halpern R; Mody RR; Fuldeore MJ; Patel PA; Mikuls TR
Curr Med Res Opin; 2009 Jul; 25(7):1711-9. PubMed ID: 19485724
[TBL] [Abstract][Full Text] [Related]
25. Abuse potential of carisoprodol: a retrospective review of Idaho Medicaid pharmacy and medical claims data.
Owens C; Pugmire B; Salness T; Culbertson V; Force R; Cady P; Steiner J
Clin Ther; 2007 Oct; 29(10):2222-5. PubMed ID: 18042478
[TBL] [Abstract][Full Text] [Related]
26. Frequency and clinical relevance of potential cytochrome P450 drug interactions in a psychiatric patient population - an analysis based on German insurance claims data.
Ostermann JK; Berghöfer A; Andersohn F; Fischer F
BMC Health Serv Res; 2016 Sep; 16(1):482. PubMed ID: 27608830
[TBL] [Abstract][Full Text] [Related]
27. Epidemiology and economic burden of brain metastases among patients with primary breast cancer: results from a US claims data analysis.
Pelletier EM; Shim B; Goodman S; Amonkar MM
Breast Cancer Res Treat; 2008 Mar; 108(2):297-305. PubMed ID: 17577662
[TBL] [Abstract][Full Text] [Related]
28. Measuring patient safety in ambulatory care: potential for identifying medical group drug-drug interaction rates using claims data.
Solberg LI; Hurley JS; Roberts MH; Nelson WW; Frost FJ; Crain AL; Gunter MJ; Young LR
Am J Manag Care; 2004 Nov; 10(11 Pt 1):753-9. PubMed ID: 15623265
[TBL] [Abstract][Full Text] [Related]
29. Effect of erythropoiesis-stimulating agents on healthcare utilization, costs, and outcomes in chronic kidney disease.
Maddux FW; Shetty S; del Aguila MA; Nelson MA; Murray BM
Ann Pharmacother; 2007 Nov; 41(11):1761-9. PubMed ID: 17895328
[TBL] [Abstract][Full Text] [Related]
30. Malpractice claims associated with medication management for chronic pain.
Fitzgibbon DR; Rathmell JP; Michna E; Stephens LS; Posner KL; Domino KB
Anesthesiology; 2010 Apr; 112(4):948-56. PubMed ID: 20234314
[TBL] [Abstract][Full Text] [Related]
31. Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1,080 pg versus oral transmucosal fentanyl citrate 1,600 pg and dose proportionality of FEBT 270 to 1,300 microg: a single-dose, randomized, open-label, three-period study in healthy adult volunteers.
Darwish M; Tempero K; Kirby M; Thompson J
Clin Ther; 2006 May; 28(5):715-24. PubMed ID: 16861093
[TBL] [Abstract][Full Text] [Related]
32. Impact of initiation timing of SSRI or SNRI on depressed adolescent healthcare utilization and costs.
Yu AP; Ben-Hamadi R; Wu EQ; Kaltenboeck A; Bergman R; Xie J; Blum S; Erder MH
J Med Econ; 2011; 14(4):508-15. PubMed ID: 21692605
[TBL] [Abstract][Full Text] [Related]
33. Screening for potential prescription opioid misuse in a michigan medicaid population.
Braker LS; Reese AE; Card RO; Van Howe RS
Fam Med; 2009; 41(10):729-34. PubMed ID: 19882397
[TBL] [Abstract][Full Text] [Related]
34. Impact of comorbid depression or anxiety on patterns of treatment and economic outcomes among patients with diabetic peripheral neuropathic pain.
Boulanger L; Zhao Y; Foster TS; Fraser K; Bledsoe SL; Russell MW
Curr Med Res Opin; 2009 Jul; 25(7):1763-73. PubMed ID: 19505204
[TBL] [Abstract][Full Text] [Related]
35. Medication adherence before an increase in antihypertensive therapy: a cohort study using pharmacy claims data.
Grant RW; Singer DE; Meigs JB
Clin Ther; 2005 Jun; 27(6):773-81. PubMed ID: 16117984
[TBL] [Abstract][Full Text] [Related]
36. Management of drug-drug interactions: considerations for special populations--focus on opioid use in the elderly and long term care.
Lynch T
Am J Manag Care; 2011 Sep; 17 Suppl 11():S293-8. PubMed ID: 21999762
[TBL] [Abstract][Full Text] [Related]
37. Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.
Pawaskar MD; Camacho FT; Anderson RT; Cobden D; Joshi AV; Balkrishnan R
Clin Ther; 2007 Jun; 29(6 Pt 1):1294-305. PubMed ID: 18036391
[TBL] [Abstract][Full Text] [Related]
38. Relationship between early opioid prescribing for acute occupational low back pain and disability duration, medical costs, subsequent surgery and late opioid use.
Webster BS; Verma SK; Gatchel RJ
Spine (Phila Pa 1976); 2007 Sep; 32(19):2127-32. PubMed ID: 17762815
[TBL] [Abstract][Full Text] [Related]
39. Duloxetine compliance and its association with healthcare costs among patients with diabetic peripheral neuropathic pain.
Wu N; Chen S; Boulanger L; Fraser K; Bledsoe SL; Zhao Y
J Med Econ; 2009 Sep; 12(3):192-202. PubMed ID: 19705975
[TBL] [Abstract][Full Text] [Related]
40. Opioid use by patients in an orthopedics spine clinic.
Mahowald ML; Singh JA; Majeski P
Arthritis Rheum; 2005 Jan; 52(1):312-21. PubMed ID: 15641058
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
